| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/28/2023 | Candel Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 90k | $1.29 | $116.1k | | 04/28/2023 |
| 03/14/2023 | Acer Therapeutics Inc. | ACER | Grant | Stock Option (right to buy) | 20k | $1.67 | $33.4k | | 03/14/2023 |
| 12/09/2022 | Candel Therapeutics, Inc. | | Purchase | Common Stock | 2.5k | $1.93 | $4.8k | | 12/08/2022 |
| 12/08/2022 | Candel Therapeutics, Inc. | | Purchase | Common Stock | 3.1k | $1.69 | $5.2k | | 12/08/2022 |
| 11/28/2022 | Candel Therapeutics, Inc. | | Grant | Common Stock | 90.9k | $0.00 | $0 | | 11/28/2022 |
| 09/21/2022 | Candel Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 230k | $3.21 | $738.3k | | 09/21/2022 |
| 01/14/2022 | Acer Therapeutics Inc. | ACER | Grant | Stock Option (right to buy) | 18.5k | $2.21 | $40.9k | | 01/14/2022 |
| 01/15/2021 | Acer Therapeutics Inc. | ACER | Grant | Stock Option (right to buy) | 15k | $3.85 | $57.8k | | 01/15/2021 |
| 02/28/2020 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 30k | $0.00 | $0 | | 02/28/2020 |
| 02/28/2020 | Akebia Therapeutics, Inc. | AKBA | Sale | Common Stock | 7k | $8.70 | $60.7k | | 02/28/2020 |
| 02/28/2020 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 45k | $8.87 | $399.2k | | 02/28/2020 |
| 01/02/2020 | Acer Therapeutics Inc. | ACER | Grant | Stock Option (right to buy) | 9k | $3.79 | $34.1k | | 01/02/2020 |
| 04/11/2019 | Akebia Therapeutics, Inc. | AKBA | Disposition | Common Stock | 13.1k | $7.70 | $101.2k | | 04/11/2019 |
| 02/01/2019 | Acer Therapeutics Inc. | ACER | Grant | Employee Stock Option (right to buy) | 6k | $24.46 | $146.8k | | 02/01/2019 |
| 12/12/2018 | Akebia Therapeutics, Inc. | AKBA | Payment of Exercise | Common Stock | 22.2k | $8.94 | $198.8k | | 12/12/2018 |
| 02/28/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 19.5k | $0.00 | $0 | | 02/28/2018 |
| 02/28/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Employee Stock Option (Right to buy) | 27.7k | $14.30 | $396.1k | | 02/28/2018 |
| 02/21/2017 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 47.5k | $0.00 | $0 | | 02/21/2017 |
| 02/21/2017 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 30k | $0.00 | $0 | | 02/21/2017 |
| 02/22/2016 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to Buy) | 39.6k | $7.70 | $305.3k | | 02/22/2016 |
| 02/22/2016 | Akebia Therapeutics, Inc. | AKBA | Grant | Common Stock | 26k | $0.00 | $0 | | 02/22/2016 |
| 03/06/2015 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to Buy) | 45k | $11.15 | $501.8k | | 03/06/2015 |
| 11/26/2014 | Akebia Therapeutics, Inc. | AKBA | Purchase | Common Stock | 1000 | $13.22 | $13.2k | | 11/26/2014 |
| 05/14/2014 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to Buy) | 21.7k | $22.80 | $494k | | 05/14/2014 |
| 03/25/2014 | Akebia Therapeutics, Inc. | AKBA | Purchase | Common Stock | 4k | $17.00 | $68k | | 03/25/2014 |
| 05/08/2013 | Alaunos Therapeutics, Inc. | ZIOP | Payment of Exercise | Common Stock | 2.6k | $1.65 | $4.3k | | 05/08/2013 |
| 12/31/2012 | Alaunos Therapeutics, Inc. | ZIOP | Grant | Employee Stock Option (right to buy) | 150k | $4.16 | $624k | | 12/31/2012 |